SCHEMBL4354048

SCHEMBL4354048

[2H]C([2H])(Br)CC([2H])([2H])Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13992311 0.89
SCHEMBL18911589 0.77
1,2-Dibromoethane SCHEMBL1448860 0.76
SCHEMBL13916487 0.71
Dibromomethane SCHEMBL20701 0.68
SCHEMBL3761033 0.67
SCHEMBL2289057 0.67
2-Bromoethanol SCHEMBL13916048 0.63
Bromoethanamine SCHEMBL12391152 0.63
SCHEMBL18806904 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090209550-A1 SUBSTITUTED TRIAZOLOPYRIDINES AUSPEX PHARMACEUTICALS, INC. (US) 2009-08-20 US disclosed
US-20090209550-A1 SUBSTITUTED TRIAZOLOPYRIDINES AUSPEX PHARMACEUTICALS, INC. (US) 2009-08-20 US disclosed
US-20090062182-A1 DEUTERIUM-ENRICHED DALBAVANCIN PROTIA, LLC (US) 2009-03-05 US disclosed